Loading clinical trials...
Loading clinical trials...
Up to 25% of colorectal cancer (CRC) patients are diagnosed with liver metastases, which is the most common site of metastasis, already during the primary tumor diagnosis. Another 30% of the patients ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Rigshospitalet, Denmark
NCT05577143 · Cancer Colorectal
NCT07091032 · Cancer Colorectal, Cancer Cervix, and more
NCT04258813 · Blood Pressure, Hypertension, and more
NCT04684862 · Colorectal Cancer Metastatic to Liver, Intrahepatic Cholangiocarcinoma
NCT07191418 · Pancreatic Cancer Metastatic to Liver
Rigshospitalet (CFAS)
Copenhagen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions